{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:26:59Z","timestamp":1791340019697,"version":"4.3.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007869","name":"Secretar\u00eda General de Ciencia y Tecnolog\u00eda , Universidad Nacional del Sur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010442","name":"Universidad Nacional de C\u00f3rdoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.heliyon.2020.e03869","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T17:27:50Z","timestamp":1588613270000},"page":"e03869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Human parvovirus B19 frequency among blood donors after an epidemic outbreak: relevance of the epidemiological scenario for transfusion medicine"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-3323","authenticated-orcid":false,"given":"Mar\u00eda Pilar","family":"Adamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Rivadera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Rodr\u00edguez-Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-1370","authenticated-orcid":false,"given":"Mauro","family":"Pedranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Carrizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2020.e03869_bib1","article-title":"ICTV virus taxonomy profile: parvoviridae","volume":"1\u20132","author":"Cotmore","year":"2019","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000357650","article-title":"Parvovirus B19 infections and blood counts in blood donors","volume":"41","author":"Juhl","year":"2014","journal-title":"Transfus. Med. Hemotherapy"},{"key":"10.1016\/j.heliyon.2020.e03869_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/vox.12162","article-title":"Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors","volume":"107","author":"Juhl","year":"2014","journal-title":"Vox Sang."},{"key":"10.1016\/j.heliyon.2020.e03869_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/vox.12295","article-title":"Look-back study on recipients of Parvovirus B19 ( B19V ) DNA-positive blood components","volume":"109","author":"Juhl","year":"2015","journal-title":"Vox Sang."},{"key":"10.1016\/j.heliyon.2020.e03869_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00166","article-title":"Recent advances in replication and infection of human parvovirus B19","volume":"8","author":"Ganaie","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/CMR.00040-16","article-title":"Human parvoviruses","volume":"30","author":"Qiu","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.heliyon.2020.e03869_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fmed.2018.00004","article-title":"Parvovirus B19: what is the relevance in transfusion medicine?","volume":"5","author":"Juhl","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2020.e03869_bib8","first-page":"1","article-title":"Guidance for industry use in medical product development to support labeling claims guidance for industry","author":"FDA","year":"2009","journal-title":"Clin. Fed. Regist."},{"key":"10.1016\/j.heliyon.2020.e03869_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/10245332.2016.1183288","article-title":"Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion- dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease","volume":"22","author":"Karrasch","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.heliyon.2020.e03869_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/trf.14088","article-title":"Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels","volume":"57","author":"Nagaharu","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/trf.12153","article-title":"Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived","volume":"53","author":"Soucie","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib12","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2169\/internalmedicine.50.5458","article-title":"Erythroid crisis caused by parvovirus B19 transmitted","volume":"50","author":"Tsukada","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.heliyon.2020.e03869_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1537-2995.2010.02780.x","article-title":"Recipients potentially infected with parvovirus B19 by red blood cell products","volume":"51","author":"Hourfar","year":"2011","journal-title":"Transfus. Complicat."},{"key":"10.1016\/j.heliyon.2020.e03869_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/0973-6247.83239","article-title":"Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units Full Text Introduction","volume":"5","author":"Kishore","year":"2011","journal-title":"Asian J. Transfus. Sci."},{"key":"10.1016\/j.heliyon.2020.e03869_bib15","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1111\/j.1537-2995.2009.02279.x","article-title":"Emerging infectious disease agents and their potential threat to transfusion safety","volume":"49","author":"Stramer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib16","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1537-2995.2010.03035.x","article-title":"Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors","volume":"51","author":"Lee","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1537-2995.2008.01704.x","article-title":"Persistent infection by human parvovirus B19 in qualified blood donors","volume":"48","author":"Matsukara","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/tme.12113","article-title":"Frequent human parvovirus B19 DNA occurrence and high seroprevalence in haemophilic patients from a non-metropolitan blood centre, Brazil","volume":"24","author":"Slavov","year":"2014","journal-title":"Transfus. Med."},{"key":"10.1016\/j.heliyon.2020.e03869_bib19","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/jmv.25450","article-title":"Parvovirus B19 in South African blood donors","volume":"91","author":"Francois","year":"2019","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/jmv.25195","article-title":"Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors","volume":"90","author":"Zadsar","year":"2018","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12288-015-0607-1","article-title":"Prevalence and viral load of human parvovirus B19 (B19V) among blood donors in South-East Brazil","volume":"32","author":"Slavov","year":"2016","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"10.1016\/j.heliyon.2020.e03869_bib22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/jmv.25453","article-title":"Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil","volume":"91","author":"Slavov","year":"2019","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1099\/jmm.0.000957","article-title":"Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil","volume":"68","author":"Slavov","year":"2019","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1017\/S0950268811000823","article-title":"Infection and immunity for human parvovirus B19 in patients with febrile exanthema","volume":"140","author":"Pedranti","year":"2012","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.heliyon.2020.e03869_bib25","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1099\/jmm.0.000629","article-title":"Parvovirus B19 in HIV+ adult patients with different CD4+ lymphocyte counts","volume":"66","author":"Pedranti","year":"2017","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1423-0410.2007.00957.x","article-title":"Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays","volume":"93","author":"Koppelman","year":"2007","journal-title":"Vox Sang."},{"key":"10.1016\/j.heliyon.2020.e03869_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1423-0410.2011.01541.x","article-title":"Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays","volume":"102","author":"Baylis","year":"2012","journal-title":"Vox Sang."},{"key":"10.1016\/j.heliyon.2020.e03869_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4067\/S0034-98872011000200001","article-title":"Detecci\u00f3n de ADN de parvovirus B19 en donantes de sangre de tres hospitales en Santiago, Chile","volume":"139","author":"L\u00e9vican","year":"2011","journal-title":"Rev. Med. Chile"},{"key":"10.1016\/j.heliyon.2020.e03869_bib29","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.78.22.12169-12178.2004","article-title":"Identification and characterization of persistent human erythrovirus infection in blood donor samples","volume":"78","author":"Candotti","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib30","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/j.1537-2995.2007.01341.x","article-title":"Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay","volume":"47","author":"Schreiber","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1423-0410.2010.01423.x","article-title":"Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009","volume":"100","author":"Kooistra","year":"2011","journal-title":"Vox Sang."},{"key":"10.1016\/j.heliyon.2020.e03869_bib32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1423-0410.2003.00299.x","article-title":"Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins","volume":"84","author":"Thomas","year":"2003","journal-title":"Vox Sang."},{"key":"10.1016\/j.heliyon.2020.e03869_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tracli.2015.11.006","article-title":"Update of the human parvovirus B19 biology","volume":"23","author":"Servant-Delmas","year":"2016","journal-title":"Transfus. Clin. Biol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib34","first-page":"1","article-title":"Existence of various human parvovirus B19 genotypes in Chinese plasma pools\u00a0: intergenotypic recombinant variants and new genotypes","author":"Jia","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.heliyon.2020.e03869_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES.2016.21.4.30116","article-title":"Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant , Bulgaria , 2004 to 2013","volume":"21","author":"Ivanova","year":"2016","journal-title":"Euro Surveill."},{"key":"10.1016\/j.heliyon.2020.e03869_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0950268815000230","article-title":"Parvovirus B19V infection in Israel\u00a0: prevalence and occurrence of acute infection between 2008 and 2013","volume":"144","author":"Mor","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.heliyon.2020.e03869_bib37","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1017\/S0950268804002730","article-title":"Parvovirus B19 viraemia in Dutch blood donors","volume":"132","author":"Zaaijer","year":"2004","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.heliyon.2020.e03869_bib38","first-page":"47","article-title":"Prevalencia de anticuerpos antirrub\u00e9ola y antiparvovirus B19 en embarazadas de la ciudad de C\u00f3rdoba y en mujeres en edad f\u00e9rtil de la ciudad de Villa Mercedes, San Luis","volume":"39","author":"Pedranti","year":"2007","journal-title":"Rev. Argent. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib39","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1537-2995.2011.03067.x","article-title":"The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers","volume":"51","author":"Ke","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjd.15382","article-title":"Detection of human parvovirus B19 DNA in 22% of 1815 cutaneous biopsies of a wide variety of dermatological conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance","volume":"177","author":"Santonja","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms14930","article-title":"Extinct type of human parvovirus B19 persists in tonsillar B cells","volume":"8","author":"Py\u00f6ri\u00e4","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2020.e03869_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/00365549709035872","article-title":"Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology","volume":"29","author":"Soderlund","year":"1997","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2020.e03869_bib43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1537-2995.2012.03904.x","article-title":"A\u00a0comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010","volume":"53","author":"Dorsey","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4067\/S0034-98872007000400005","article-title":"Seroprevalencia de anticuerpos IgG contra parvovirus B19 en donantes de sangre de hospitales en Santiago, Chile","volume":"135","author":"Gaggero","year":"2007","journal-title":"Rev. Med. Chile"},{"key":"10.1016\/j.heliyon.2020.e03869_bib45","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jmv.23358","article-title":"Molecular and phylogenetic analyses of human parvovirus B19 isolated from Brazilian patients with sickle cell disease and b -thalassemia major and healthy blood donors","volume":"1665","author":"Slavov","year":"2012","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib46","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1177\/0961203310375438","article-title":"Parvovirus B19 and C-reactive protein in blood bank donors\u00a0: implications for hygiene hypothesis research","volume":"19","author":"O\u2019Bryan","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.heliyon.2020.e03869_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268899003817","article-title":"The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world","volume":"124","author":"Kelly","year":"2000","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.heliyon.2020.e03869_bib48","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jmv.23557","article-title":"A\u00a0clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma","volume":"85","author":"Porignaux","year":"2013","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2020.e03869_bib49","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1537-2995.2010.02995.x","article-title":"Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay","volume":"51","author":"Koppelman","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2020.e03869_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/bdra.23588","article-title":"Parvovirus B19 infection during pregnancy and risks to the fetus","volume":"109","author":"Ornoy","year":"2017","journal-title":"Birth Defect. Res."},{"key":"10.1016\/j.heliyon.2020.e03869_bib51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1017\/S1047951114000225","article-title":"A\u00a0case of parvovirus B19-induced pure red cell aplasia in a child following heart transplant","volume":"25","author":"Kelleher","year":"2015","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.heliyon.2020.e03869_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v9060149","article-title":"Impact of parvovirus B19 viremia in liver transplanted children on anemia: a retrospective study","volume":"9","author":"W\u00fcrdinger","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2020.e03869_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1386-6532(02)00104-X","article-title":"B19 virus infection in renal transplant recipients","volume":"26","author":"Cavallo","year":"2003","journal-title":"J.\u00a0Clin. Virol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020307143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020307143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:25:54Z","timestamp":1775201154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020307143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2405844020307143"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03869","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human parvovirus B19 frequency among blood donors after an epidemic outbreak: relevance of the epidemiological scenario for transfusion medicine","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e03869"}}